🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
101.85
-2.03 (-1.95%)
At close: Nov 20, 2026, 4:00 PM EST
101.94
+0.09 (0.09%)
After-hours: Nov 20, 2026, 7:59 PM EST

Edwards Lifesciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,6756,0685,4405,0104,4645,233
Revenue Growth
13.44%11.55%8.57%12.23%-14.69%19.29%
Cost of Revenue
1,4671,3341,118978.4722.11,249
Gross Profit
5,2084,7334,3224,0323,7423,984
Selling, General & Admin
2,2462,0841,7891,5811,3571,494
Research & Development
1,0911,0791,053962.9843.6903.1
Other Operating Expenses
-52.8-67.2-0.3---
Operating Expenses
3,2843,0962,8412,5442,2002,397
Operating Income
1,9241,6381,4811,4871,5421,587
Interest Expense
-20.4-20.4-19.8-17.6-19.2-18.4
Interest & Investment Income
162.5168.8120.367.235.517.4
Currency Exchange Gain (Loss)
0.80.77.11015
Other Non Operating Income (Expenses)
281.56.83.4-10.8
EBT Excluding Unusual Items
2,0941,7891,5951,5501,5591,601
Merger & Restructuring Charges
-21.3-19.1-61--62.3-
Gain (Loss) on Sale of Investments
-266.3-143.654.4-0.7-1.1-2.8
Asset Writedown
-220.2-40----
Legal Settlements
-239.3-325.4-40.4-203.5-15.8-20.6
Other Unusual Items
85.112.5-26.235.8124.1
Pretax Income
1,4321,2731,5481,3721,5201,702
Income Tax Expense
444.7216.9152.1152.4195.5198.9
Earnings From Continuing Operations
987.71,0561,3961,2201,3241,503
Earnings From Discontinued Operations
2713.42,774179.4197.9-
Net Income to Company
1,0151,0694,1701,3991,5221,503
Minority Interest in Earnings
6.64.14.93--
Net Income
1,0211,0744,1751,4021,5221,503
Net Income to Common
1,0211,0744,1751,4021,5221,503
Net Income Growth
-25.34%-74.28%197.68%-7.85%1.25%82.55%
Shares Outstanding (Basic)
578585598607619623
Shares Outstanding (Diluted)
579586599609624631
Shares Change
-1.48%-2.25%-1.66%-2.37%-1.11%-0.11%
EPS (Basic)
1.771.846.982.312.462.41
EPS (Diluted)
1.761.836.972.302.442.38
EPS Growth
-24.39%-73.70%202.39%-5.44%2.40%83.08%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,4241,335289.9642.8973.61,406
Free Cash Flow Per Share
2.462.280.481.051.562.23
Gross Margin
78.02%78.01%79.46%80.47%83.82%76.13%
Operating Margin
28.82%26.99%27.22%29.69%34.54%30.32%
Profit Margin
15.30%17.69%76.75%27.99%34.09%28.73%
Free Cash Flow Margin
21.34%22.00%5.33%12.83%21.81%26.88%
EBITDA
2,0951,7951,6241,6091,6811,721
EBITDA Margin
31.38%29.58%29.85%32.12%37.67%32.90%
D&A For EBITDA
171.2156.6143.2122139.6134.8
EBIT
1,9241,6381,4811,4871,5421,587
EBIT Margin
28.82%26.99%27.22%29.69%34.54%30.32%
Effective Tax Rate
31.05%17.04%9.83%11.11%12.87%11.69%
SEC Filings: 10-K · 10-Q